We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$906M
AUM Growth
+$185M
Cap. Flow
+$148M
Cap. Flow %
16.31%
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.7M
2
DB icon
Deutsche Bank
DB
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
COR icon
Cencora
COR
+$13.9M
5
OCR
OMNICARE INC
OCR
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Consumer Discretionary 11.57%
3 Healthcare 7.92%
4 Utilities 7.88%
5 Materials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
376
CBRE Group
CBRE
$43.3B
$10.1K ﹤0.01%
262
-567
-68% -$19.6K
WES
377
DELISTED
Western Gas Partners Lp
WES
$9.55K ﹤0.01%
145
-142
-49% -$9.81K
DINO icon
378
HF Sinclair
DINO
$16.2B
$9.3K ﹤0.01%
231
-2,452
-91% -$94K
MDY icon
379
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
$9.15K ﹤0.01%
33
-71
-68% -$19.1K
MMP
380
DELISTED
Magellan Midstream Partners, L.P.
MMP
$9.13K ﹤0.01%
119
-121
-50% -$9.67K
CLMT icon
381
Calumet Specialty Products
CLMT
$3.7B
$9.02K ﹤0.01%
375
-377
-50% -$9.54K
EXR icon
382
Extra Space Storage
EXR
$32.3B
$8.92K ﹤0.01%
132
-323
-71% -$21.2K
MFA
383
MFA Financial
MFA
$932M
$8.81K ﹤0.01%
280
-514
-65% -$16.3K
SPG icon
384
Simon Property Group
SPG
$76.4B
$8.61K ﹤0.01%
44
-103
-70% -$20K
O icon
385
Realty Income
O
$61.1B
$8.56K ﹤0.01%
171
-418
-71% -$20.9K
GGP
386
DELISTED
GGP Inc.
GGP
$8.54K ﹤0.01%
289
-726
-72% -$21.7K
NNN icon
387
NNN REIT
NNN
$9.29B
$8.52K ﹤0.01%
208
-479
-70% -$19.9K
ACC
388
DELISTED
American Campus Communities, Inc.
ACC
$8.45K ﹤0.01%
197
-480
-71% -$20.5K
MAC icon
389
Macerich
MAC
$7.4B
$8.43K ﹤0.01%
100
-276
-73% -$24.1K
OHI icon
390
Omega Healthcare
OHI
$15.3B
$8.2K ﹤0.01%
202
-499
-71% -$20.7K
RYN icon
391
Rayonier
RYN
$6.67B
$8.03K ﹤0.01%
328
-543
-62% -$13.8K
UGP icon
392
Ultrapar
UGP
$6.66B
$7.96K ﹤0.01%
788
-1,374
-64% -$13.4K
TAP icon
393
Molson Coors Class B
TAP
$8.02B
$7.59K ﹤0.01%
102
-655
-87% -$49.4K
ENIA
394
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$6.84K ﹤0.01%
781
-5,330
-87% -$45.7K
TX icon
395
Ternium
TX
$9.43B
$6.63K ﹤0.01%
367
-26
-7% -$453
WPZ
396
DELISTED
Williams Partners L.P.
WPZ
$6.59K ﹤0.01%
+134
New +$6.54K
FANG icon
397
Diamondback Energy
FANG
$56B
$5.99K ﹤0.01%
78
EOCC
398
DELISTED
Enel Generacion Chile S.A.
EOCC
$5.99K ﹤0.01%
192
-139
-42% -$4.27K
WFM
399
DELISTED
Whole Foods Market Inc
WFM
$5.88K ﹤0.01%
113
-720
-86% -$38.6K
ALU
400
PUT
DELISTED
Alcatel-Lucent
ALU
$5.84K ﹤0.01%
+310
New +$1.14K

Similar funds

Exane Derivatives's Q1 2015 Portfolio in Review

As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Exane Derivatives deployed $148M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.

  • Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
  • Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
  • Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
  • Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
  • Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.